IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 229 filers reported holding IVERIC BIO INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $77,530,682 | -21.6% | 1,970,785 | -51.5% | 0.03% | -23.8% |
| Q1 2023 | $98,950,962 | +9.2% | 4,067,035 | -3.9% | 0.04% | +2.4% |
| Q4 2022 | $90,605,343 | +113.9% | 4,231,917 | +79.2% | 0.04% | +95.2% |
| Q3 2022 | $42,358,000 | +4081.4% | 2,361,070 | +2142.2% | 0.02% | – |
| Q2 2022 | $1,013,000 | -41.4% | 105,300 | +2.4% | 0.00% | -100.0% |
| Q1 2022 | $1,730,000 | +0.9% | 102,800 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $1,714,000 | +2.9% | 102,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,665,000 | +205.5% | 102,500 | +18.8% | 0.00% | – |
| Q2 2021 | $545,000 | +26.7% | 86,300 | +24.2% | 0.00% | – |
| Q1 2021 | $430,000 | -17.5% | 69,500 | -7.8% | 0.00% | – |
| Q4 2020 | $521,000 | +22.6% | 75,400 | 0.0% | 0.00% | – |
| Q3 2020 | $425,000 | +10.4% | 75,400 | 0.0% | 0.00% | – |
| Q2 2020 | $385,000 | – | 75,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,729,041 | $10,685,000 | 4.26% |
| Soleus Capital Management, L.P. | 3,380,979 | $20,894,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 1,579,093 | $9,759,000 | 3.52% |
| Stonepine Capital Management, LLC | 875,180 | $5,409,000 | 2.92% |
| Samsara BioCapital, LLC | 2,372,476 | $14,664,000 | 2.70% |
| Ghost Tree Capital, LLC | 1,125,000 | $6,953,000 | 1.63% |
| Octagon Capital Advisors LP | 680,036 | $4,203,000 | 1.58% |
| Altium Capital Management LP | 902,633 | $5,578,000 | 1.55% |
| Vivo Capital, LLC | 5,966,527 | $36,873,000 | 1.30% |
| FRAZIER MANAGEMENT LLC | 2,544,500 | $15,725,000 | 1.26% |